34 / 2025 Medicalgorithmics S.A. signs a contract with a minimum annual value of PLN 439.2 thousand for the provision of ECG diagnostic service
Current Report No: 34 / 2025 Date: November 3, 2025 Legal Basis: Article 17(1) of the MAR Regulation – Confidential Information The Management Board of Medicalgorithmics S.A. (“Company”, “Medicalgorithmics”) announces that on November 3, 2025, the Company signed an agreement (“Agreement”) with a partner from England (“Contractor”). Under the Agreement, Medicalgorithmics S.A. will provide the […]
33/2025 Change of the date of publication of the consolidated report for the third quarter of 2025
Current Report No.: 33/2025 Date of preparation: October 20, 2025 Legal basis: Article 56(1)(2) of the Act on Public Offering – current and periodic information The Management Board of Medicalgorithmics S.A., based in Warsaw (the “Company”), hereby announces a change in the publication date of the consolidated quarterly report for the third quarter of 2025 […]
32 / 2025 Notification from a shareholder pursuant to Article 69 of the Act on Public Offering regarding a change in the total number of votes in the Company
Current Report No.: 32/2025 Date: October 13, 2025 Legal basis: Art. 70(1) of the Act on Public Offering – acquisition or disposal of a significant block of shares The Management Board of Medicalgorithmics S.A. with its registered office in Warsaw (the “Company”) hereby informs that today it received a notification from Powszechne Towarzystwo Emerytalne PZU […]
31/2025 Introduction of shares to trading on the main market operated by the Warsaw Stock Exchange following the assimilation of shares in the National Depository for Securities. Setting the date of the first listing of the Company’s series K shares after their assimilation with shares traded on the main market.
Current Report No.: 31/2025 Date: October 13, 2025 Legal Basis: Article 56(1)(2) of the Act on Public Offering – Current and Periodic Information The Management Board of Medicalgorithmics S.A. with its registered office in Warsaw (the “Issuer”, the “Company”) hereby announces that on 13 October 2025 it was informed that the Management Board of the […]
30 / 2025 Estimated sales revenue for Q3 2025 amounted to PLN 7.2 million – a 38% year-on-year increase Current
Report No.: 30/2025 Date of preparation: 6 October 2025 Legal basis: Article 17(1) of the MAR Regulation – inside information Medicalgorithmics S.A., with its registered office in Warsaw (the “Company”, the “Issuer”), hereby announces that in the third quarter of 2025, the estimated, unaudited consolidated sales revenue of the Medicalgorithmics Group amounted to a total […]
29 / 2025 Informationon convening the Extraordinary General Meeting of Medicalgorithmics S.A.together with the content of draft resolutions
Current report no.: 29/2025 Date: October 6, 2025 Legal basis: Article 56 (1) (2) of the Offering Act – current and periodic information Management Board of Medicalgorithmics S.A. with its registered office in Warsaw (the “Company”) hereby informs about the convening of the Extraordinary General Meeting of the Company on November 3, 2025, at 2:00 […]
28 / 2025 One of the largest American IDTFs has increased by 118% the daily number of ECG studies analyzed using Medicalgorithmics’ proprietary software.
Date of preparation: 24 September 2025 Legal basis: Article 17(1) of MAR – inside information With reference to current report No. 2/2025 dated January 24, 2025, in which Medicalgorithmics S.A., with its registered office in Warsaw (“Company”; “Issuer”), informed about the conclusion of a significant agreement (“Agreement”) with a U.S.-based diagnostic center (IDTF, the “Partner”), […]
27/2025 Conversion of registered shares of series K into bearer shares
Current Report No: 27/2025 Date: 23.09.2025 Legal Basis: Article 17(1) of the MAR Regulation – confidential information. The Management Board of Medicalgorithmics S.A. with its registered office in Warsaw (“Company”; “Issuer”) informs that on September 23, 2025 it adopted a resolution on the conversion of series K ordinary registered shares into ordinary bearer shares (“Resolution”). […]
26 / 2025 Shareholder notification of a change in the total number of votes in the Company
Current Report No.: 26/2025Date: 02.09.2025Legal basis: Art. 70(1) of the Act on Public Offering – acquisition or disposal of a significant block of shares The Management Board of Medicalgorithmics S.A. with its registered office in Warsaw (the “Company”) hereby informs that today it has received notifications of a reduction in the threshold of 5% of […]
25 / 2025 Notifications of exceeding the threshold of the total number of votes in the Company
Current Report No.: 25/2025Date: August 29, 2025Legal basis: Art. 70(1) of the Act on Public Offering – acquisition or disposal of a significant block of shares. The Management Board of Medicalgorithmics S.A., with its registered office in Warsaw (the “Company”), hereby informs that today it has received notifications that the following entities have exceeded the […]
24 / 2025 Notification of a shareholder pursuant to Article 69 of the Act on Public Offering
Current Report No.: 24/2025Date: August 29, 2025Legal basis: Art. 70(1) of the Act on Public Offering – acquisition or disposal of a significant block of shares. The Management Board of Medicalgorithmics S.A., with its registered office in Warsaw (the “Company”), hereby informs that today it received a notification from a shareholder of the Company – […]
23 / 2025 Notification of a closely related person’s transaction received in accordance with Article 19 of the MAR Regulation
Current Report No.: 23/2025Date: August 29, 2025Legal basis: Article 19(3) of MAR – information on transactions performed by persons discharging managerial responsibilities. The Management Board of Medicalgorithmics S.A., with its registered office in Warsaw (the “Company”), hereby informs that it has received today a notification from Biofund Capital Management Limited Liability Company with its registered […]